These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9179183)

  • 81. 3D proton MR spectroscopic imaging of prostate cancer using a standard spine coil at 1.5 T in clinical routine: a feasibility study.
    Lichy MP; Pintaske J; Kottke R; Machann J; Anastasiadis A; Roell S; Hennenlotter J; Diergarten T; Schick F; Stenzl A; Claussen CD; Schlemmer HP
    Eur Radiol; 2005 Apr; 15(4):653-60. PubMed ID: 15627193
    [TBL] [Abstract][Full Text] [Related]  

  • 82. MR spectroscopy of the prostate at 3T: measurements of relaxation times and quantification of prostate metabolites using water as an internal reference.
    Weis J; Ortiz-Nieto F; Ahlström H
    Magn Reson Med Sci; 2013 Dec; 12(4):289-96. PubMed ID: 24172792
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T.
    Cunningham CH; Vigneron DB; Marjanska M; Chen AP; Xu D; Hurd RE; Kurhanewicz J; Garwood M; Pauly JM
    Magn Reson Med; 2005 May; 53(5):1033-9. PubMed ID: 15844147
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo.
    Thomas MA; Lange T; Velan SS; Nagarajan R; Raman S; Gomez A; Margolis D; Swart S; Raylman RR; Schulte RF; Boesiger P
    MAGMA; 2008 Nov; 21(6):443-58. PubMed ID: 18633659
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI.
    Liney GP; Turnbull LW; Lowry M; Turnbull LS; Knowles AJ; Horsman A
    Magn Reson Imaging; 1997; 15(10):1177-86. PubMed ID: 9408138
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The aging effect on prostate metabolite concentrations measured by
    Dezortova M; Jiru F; Skoch A; Capek V; Ryznarova Z; Vik V; Hajek M
    MAGMA; 2017 Feb; 30(1):65-74. PubMed ID: 27522359
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Magnetic resonance spectroscopy in prostate disease: diagnostic possibilities and future developments.
    Narayan P; Kurhanewicz J
    Prostate Suppl; 1992; 4():43-50. PubMed ID: 1374177
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Comparison of the accuracy of manual and automatic evaluation of MR spectra in prostate carcinoma].
    Weber C; Zechmann CM; Kelm BM; Zamecnik P; Hendricks D; Waldherr R; Hamprecht FA; Delorme S; Bachert P; Ikinger U
    Urologe A; 2007 Sep; 46(9):1252. PubMed ID: 17676295
    [No Abstract]   [Full Text] [Related]  

  • 89. Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours.
    Schwarz AJ; Maisey NR; Collins DJ; Cunningham D; Huddart R; Leach MO
    Br J Radiol; 2002 Dec; 75(900):959-66. PubMed ID: 12515704
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
    García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
    Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Novel biomarker for prostate cancer diagnosis by MRS.
    Sarkar BK; Chakraborty C; Sharma AR; Bae KJ; Sharma G; Doss GP; Dutta D; Ding S; Ganbold B; Nam JS; Lee SS
    Front Biosci (Landmark Ed); 2014 Jun; 19(7):1186-201. PubMed ID: 24896344
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study.
    Kurhanewicz J; Dahiya R; Macdonald JM; Chang LH; James TL; Narayan P
    Magn Reson Med; 1993 Feb; 29(2):149-57. PubMed ID: 8429778
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T.
    Schick F; Bongers H; Kurz S; Jung WI; Pfeffer M; Lutz O
    Magn Reson Med; 1993 Jan; 29(1):38-43. PubMed ID: 8110206
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [MR spectroscopy of the prostate with external surface coils: clinical feasibility].
    Balique J; Cuilleron M; Veyret C
    J Radiol; 2010 Feb; 91(2):207-12. PubMed ID: 20389267
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples.
    Bertilsson H; Tessem MB; Flatberg A; Viset T; Gribbestad I; Angelsen A; Halgunset J
    Clin Cancer Res; 2012 Jun; 18(12):3261-9. PubMed ID: 22510345
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate.
    Scheenen TW; Klomp DW; Röll SA; Fütterer JJ; Barentsz JO; Heerschap A
    Magn Reson Med; 2004 Jul; 52(1):80-8. PubMed ID: 15236370
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.
    Basharat M; Jafar M; deSouza NM; Payne GS
    NMR Biomed; 2014 Apr; 27(4):459-67. PubMed ID: 24519849
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Magnetic resonance spectroscopic imaging of benign prostatic tissue: findings at 3.0 T compared to 1.5 T-initial experience.
    Chitkara M; Westphalen A; Kurhanewicz J; Qayyum A; Poder L; Reed G; Coakley FV
    Clin Imaging; 2011; 35(4):288-93. PubMed ID: 21724122
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Value of magnetic resonance imaging for early diagnosis of prostatic carcinoma in central zone].
    He H; Fan S; Li Y; Ke M; Li Y; Chen B; Yu H
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1051-4. PubMed ID: 24851886
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Bioenergetic theory of prostate malignancy.
    Costello LC; Franklin RB
    Prostate; 1994 Sep; 25(3):162-6. PubMed ID: 7520580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.